Overview
Mosapride is under investigation for the treatment and prevention of Postoperative Ileus and Gastric Peroral Endoscopic Pyloromyotomy (G-POEM). Mosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others.
Background
Mosapride is under investigation for the treatment and prevention of Postoperative Ileus and Gastric Peroral Endoscopic Pyloromyotomy (G-POEM). Mosapride has been investigated for the treatment and diagnostic of Constipation, Type 2 Diabetes, Functional Dyspepsia, Functional Constipation, and Epigastric Pain Syndrome, among others.
Indication
1.功能性消化不良伴有胃灼热、嗳气、恶心、上腹胀等消化道症状； 2.胃食管反流病； 3.糖尿病胃轻瘫； 4.胃大部切除术患者的胃功能障碍。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/02/14 | Phase 3 | Not yet recruiting | |||
2024/07/01 | Not Applicable | Not yet recruiting | |||
2023/12/05 | Not Applicable | Recruiting | Guoliang Wu | ||
2023/02/09 | Phase 1 | Not yet recruiting | |||
2021/05/27 | Not Applicable | UNKNOWN | |||
2020/07/30 | Not Applicable | Completed | |||
2020/04/17 | Not Applicable | UNKNOWN | |||
2018/03/26 | Phase 3 | Completed | |||
2017/07/21 | Phase 3 | Completed | |||
2017/06/12 | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| 枸橼酸莫沙必利胶囊 | 国药准字H20173152 | 化学药品 | 胶囊剂 | 2/25/2022 | |
| Mosapride Citrate Dispersible Tablets | 国药准字H20031110 | 化学药品 | 片剂 | 4/24/2024 | |
| Mosapride Citrate Oral Solution | 国药准字H20080373 | 化学药品 | 口服溶液剂 | 1/9/2023 | |
| Mosapride Citrate Tablets | 国药准字J20140149 | N/A | 片剂 | 4/11/2019 | |
| Mosapride Citrate Tablets | 国药准字HJ20140636 | 化学药品 | 片剂 | 9/1/2023 | |
| Mosapride Citrate Tablets | 国药准字H20203264 | 化学药品 | 片剂 | 6/17/2020 | |
| Mosapride Citrate Tablets | 国药准字HJ20140637 | 化学药品 | 片剂 | 9/1/2023 | |
| Mosapride Citrate Tablets | 国药准字H20244986 | 化学药品 | 片剂 | 9/26/2024 | |
| Mosapride Citrate Tablets | 国药准字H19990317 | 化学药品 | 片剂 | 5/20/2020 | |
| Mosapride Citrate Tablets | 国药准字H19990315 | 化学药品 | 片剂 | 6/30/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||